EFPIA Newsletter 28 April 2016

Highlight of the week     150709 IMI launches €95 million Call for proposals with focus on Alzheimer’s disease,... 09 July 2015   Antimicrobial resistance, flu, liver disease, rheumatic disease, medicines safety and data quality are the focus of the latest Call for proposals launched by the Innovative Medicines Initiative (IMI). The Call has a total budget of close on €60 million for applicants; this is matched by EFPIA companies, which pay for their own contribution to these ground-breaking projects. For more information on IMI 2 – Call 9, click here. Read more →

News     26 April 2016 160426 EFPIA to extend collaboration with Lithuania on pharmaceutical policy A new agreement for collaboration in 2017-2020 between EFPIA and Lithuania Read more →

From our blog     24 April 2016 160424 A Life-Course Approach to Vaccination Will Secure the Health of Europe’s Citizens Magdalena R. de Azero discusses the need for improvement with the use of vaccinations.... Read more →

Events Calendar     15 JUN 2016   160615 EFPIA Annual Conference 2016 Brussels, Belgium On 15 June 2016 at the Radisson Hotel Learn more →       26 MAY 2016   160526 European Conference on Rare Diseases & Orphan Products 2016 Edinburgh, Scotland Now in its 8th year Learn more →

	28 SEP 2016			160928 European Health Forum Gastein, Demographics and Diversity in Europe - New... Bad Hofgastein, Austria "Demographics and Diversity in Europe - New Solutions in Health" Learn more →

What we're reading Immunisation saves billions of lives yet preventable illness is still a threat 28 April 2016  (The Guardian) Read more → Brexit would be bad for the NHS and social care 28 April 2016  (The Guardian) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe